Hepatocyte targeting of adenine-9-beta-D-arabinofuranoside 5' -monophosphate (ara-AMP) coupled to lactosaminated albumin.
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000606:Amino Sugars / Q000378:metabolism*; D000818:Animals; D001088:Arabinonucleotides / Q000378:metabolism*; D004279:DNA, Viral / Q000235:genetics; D004482:Ectromelia, Infectious / Q000235:genetics; D005260:Female; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000382:microbiology; D051379:Mice; D009693:Nucleic Acid Hybridization; D012709:Serum Albumin / Q000378:metabolism*; D013329:Structure-Activity Relationship; D001084:Vidarabine Phosphate / Q000378:metabolism*
D000606:Amino Sugars; D001088:Arabinonucleotides; D004279:DNA, Viral; D007166:Immunosuppressive Agents; D012709:Serum Albumin; D001084:Vidarabine Phosphate; C032233:lactosamine; C010192:9-(2-hydroxy-3-nonyl)adenine; D000225:Adenine